TransMedics (TMDX) Q4 Earnings and Revenues Beat Estimates

分组1 - TransMedics reported quarterly earnings of $0.19 per share, exceeding the Zacks Consensus Estimate of $0.18 per share, and up from $0.12 per share a year ago, representing an earnings surprise of 5.56% [1] - The company achieved revenues of $121.62 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 10.19%, compared to $81.17 million in the same quarter last year [2] - TransMedics has outperformed the S&P 500, with shares increasing about 18.3% since the beginning of the year, while the S&P 500 gained 1.3% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.29 on revenues of $120.59 million, and for the current fiscal year, it is $1.43 on revenues of $523.37 million [7] - The Medical - Instruments industry, to which TransMedics belongs, is currently ranked in the top 33% of over 250 Zacks industries, indicating a favorable outlook [8]